Company Info

BioMarin

Drug Discovery & Development

Overview

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.

0 Contributors1 / 0

No authors found

1 / 0

2 Contributions1 / 1

Positive Opinion

BioMarin Receives Positive CHMP Opinion in Europe for Palynziq® (pegvaliase Injection) for Treatment of Patients with Phenylketonuria (PKU) Aged 16 and Older

BioMarin

PR-M03-19-NI-008Mar 04, 2019

Clinical Trials

BioMarin Doses First Participant in Phase 2 Study of Vosoritide for Treatment of Infants and Young Children with Achondroplasia

BioMarin

PR-M06-18-NI-059Jun 18, 2018

1 / 1